Hannover Medical School, Department of Pediatric Pneumology, Allergology, and Neonatology, Hannover, Germany.
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany.
Methods Mol Biol. 2024;2713:463-479. doi: 10.1007/978-1-0716-3437-0_31.
Alveolar macrophages (AMs) represent crucial immune cells in the bronchioalveolar space of the lung. Given the important role in the host defense machinery and lung tissue homeostasis, AMs have been linked to a variety of diseases and thus represent a promising target cell type for novel therapies. The emerging importance of AM underlines the necessity to isolate and/or generate proper cellular models, which facilitate basic biology and translational science. As of yet, most studies focus on the derivation of AM from the murine system. This chapter introduces the use of human-induced pluripotent stem cell (iPSC)-derived primitive macrophages, which can be further matured towards an AM-like phenotype upon intra-pulmonary transfer into mice. We will give a brief overview on the generation of primitive iPSC-derived macrophages, which is followed by a detailed, step-by-step description of the intra-pulmonary transfer of cells and the follow-up procedures needed to isolate the iPSC-derived, AM-like cells from the lungs post-transfer. The chapter provides an alternative approach to derive human AM-like cells, which can be used to study human AM biology and to investigate novel therapeutic interventions using primitive macrophages from iPSC.
肺泡巨噬细胞(AMs)是肺支气管肺泡空间中重要的免疫细胞。鉴于其在宿主防御机制和肺组织稳态中的重要作用,AMs 与多种疾病有关,因此成为新型治疗方法的有前途的靶细胞类型。AMs 的重要性日益凸显,这就必须要分离和/或生成适当的细胞模型,以促进基础生物学和转化科学的发展。到目前为止,大多数研究都集中在从鼠系统中获得 AM。本章介绍了使用人诱导多能干细胞(iPSC)衍生的原始巨噬细胞,这些细胞可以在向小鼠肺部内转移后进一步成熟为 AM 样表型。我们将简要概述原始 iPSC 衍生的巨噬细胞的生成,然后详细描述细胞的肺部内转移以及后续程序,这些程序用于在转移后从肺部中分离出 iPSC 衍生的 AM 样细胞。本章提供了一种衍生人类 AM 样细胞的替代方法,可用于研究人类 AM 生物学,并使用 iPSC 衍生的原始巨噬细胞研究新型治疗干预措施。